C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2736362
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are 4-amino-3-imidazoyl-pyrazolo[3,4-d]pyrimidine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.
La présente invention concerne des composés qui constituent de puissants antagonistes du récepteur CCR1, et qui présentent in vivo une activité anti-inflammatoire. Ces composés dérivés de 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines, conviennent particulièrement pour l'élaboration de compositions pharmaceutiques, pour le traitement de maladies médiées par CCR1, et comme témoins pour l'identification d'antagonistes compétitifs de CCR1.
Zeng Yibin
Zhang Penglie
Chemocentryx Inc.
Fetherstonhaugh & Co.
LandOfFree
4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1787823